Literature DB >> 24663496

Botulinum toxin A in functional popliteal entrapment syndrome: a new approach to a difficult diagnosis.

Florin Gandor1, Stephen Tisch, Anthony J Grabs, Anthony J Delaney, Lourens Bester, Paul Darveniza.   

Abstract

Functional Popliteal Entrapment Syndrome (FPES) is caused by compression of neurovascular structures in the popliteal fossa by hypertrophic muscles, provoking severe leg pain with exercise. Treatment is limited to myotomy of hypertrophic musculature. 8 FPES patients underwent imaging and exercise studies, before receiving botulinum toxin A injections (BTX-A) into the gastrocnemius and plantaris muscles. 81.3 % of patients reported clinical improvement on follow-up, and pathological ankle-brachial indices were normalized. BTX-A injection may present a new, safe, effective and non-invasive approach to FPES.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24663496     DOI: 10.1007/s00702-014-1197-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  16 in total

1.  Popliteal artery compression and force of active plantar flexion in young healthy volunteers.

Authors:  U Hoffmann; J Vetter; L Rainoni; A J Leu; A Bollinger
Journal:  J Vasc Surg       Date:  1997-08       Impact factor: 4.268

2.  POPLITEAL ARTERY ENTRAPMENT SYNDROME.

Authors:  J W LOVE; T J WHELAN
Journal:  Am J Surg       Date:  1965-05       Impact factor: 2.565

3.  Note on a Variation in the Course of the Popliteal Artery.

Authors:  T P Stuart
Journal:  J Anat Physiol       Date:  1879-01

Review 4.  Piriformis syndrome, diagnosis and treatment.

Authors:  Jonathan S Kirschner; Patrick M Foye; Jeffrey L Cole
Journal:  Muscle Nerve       Date:  2009-07       Impact factor: 3.217

Review 5.  Popliteal entrapment syndrome.

Authors:  Sidhartha Sinha; Jon Houghton; Peter J Holt; Matt M Thompson; Ian M Loftus; Robert J Hinchliffe
Journal:  J Vasc Surg       Date:  2011-11-23       Impact factor: 4.268

6.  Muscular abnormalities affecting the popliteal vessels.

Authors:  J Bouhoutsos; E Daskalakis
Journal:  Br J Surg       Date:  1981-07       Impact factor: 6.939

7.  The "functional" popliteal entrapment syndrome.

Authors:  D P Rignault; J L Pailler; F Lunel
Journal:  Int Angiol       Date:  1985 Jul-Sep       Impact factor: 2.789

8.  Functional popliteal artery entrapment syndrome: A poorly understood and often missed diagnosis that is frequently mistreated.

Authors:  William D Turnipseed
Journal:  J Vasc Surg       Date:  2009-05       Impact factor: 4.268

Review 9.  Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.

Authors:  F Gerald R Fowkes; Diana Rudan; Igor Rudan; Victor Aboyans; Julie O Denenberg; Mary M McDermott; Paul E Norman; Uchechukwe K A Sampson; Linda J Williams; George A Mensah; Michael H Criqui
Journal:  Lancet       Date:  2013-08-01       Impact factor: 79.321

10.  Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers.

Authors:  A Sebastian Schroeder; Birgit Ertl-Wagner; Stefanie Britsch; J Michael Schröder; Stefan Nikolin; Joachim Weis; Wolfgang Müller-Felber; Inga Koerte; Maximilian Stehr; Steffen Berweck; Ingo Borggraefe; Florian Heinen
Journal:  Mov Disord       Date:  2009-07-30       Impact factor: 10.338

View more
  1 in total

1.  Functional popliteal artery entrapment syndrome: use of ultrasound guided Botox injection as a non-surgical treatment option.

Authors:  Matthew Hislop; Adam Brideaux; Sanjay Dhupelia
Journal:  Skeletal Radiol       Date:  2017-06-09       Impact factor: 2.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.